Revance Therapeutics
RVNC
#7442
Rank
A$0.51 B
Marketcap
$4.92
Share price
0.00%
Change (1 day)
-58.18%
Change (1 year)

Revance Therapeutics (RVNC) Fails to deliver data

Key failure to deliver metrics for Revance Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Revance Therapeutics (RVNC) - 3 months history

Number of shares, 3 months chart

Sep 2024Oct 20245K10K15K20K25K30K0companiesmarketcap.com

Biweekly Failures to deliver volume for Revance Therapeutics (RVNC) - since 2014

Volume in USD (price x number of shares), data since 2014 201620192022$20M$40M$60M$80M$0.1B0companiesmarketcap.com

Revance Therapeutics (RVNC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$6.83 M-84.89%
2023A$45.25 M383.15%
2022A$9.36 M-6.12%
2021A$9.97 M-56.82%
2020A$23.1 M668%
2019A$3 M-97.15%
2018A$0.10 B815.52%
2017A$11.51 M5.25%
2016A$10.93 M-46.65%
2015A$20.5 M-9.25%
2014A$22.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$0.03 MA$0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$81.31 MA$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$24.41 MA$68.86 M๐Ÿ‡บ๐Ÿ‡ธ USA